SOMERSET,
NJ – Terumo Interventional
Systems, a strategic business unit of Terumo Medical Corporation, and one of
the leading manufacturers of guidewires, catheters, sheaths, and embolization
products, today announced the nationwide availability of the AZUR® D35 Framing Coil,
the first truly detachable coil that precisely frames the targeted area for
peripheral embolization.
The new AZUR D35 Framing Coil is indicated for peripheral
embolization procedures where a scaffolding structure is needed, such as:
hypogastric artery embolization; peripheral arteriovenous malformations and
fistulas; endoleaks; visceral aneurysms; and venous applications. The
detachable embolic platform forms a spherical 3-dimensional shape when deployed
and is designed to control the first coil deployment, when a standard coil
would not suffice due to high flow and high pressures.
“The new AZUR D35 Framing Coils’ innovative technology
offers interventional radiologists and vascular surgeons options in
challenging, high-flow procedures,” said Chris Pearson, Vice President,
Marketing, Terumo Interventional Systems. “These detachable framing coils
afford greater filling capacity, packing density, and mechanical occlusion,
particularly in the treatment of high-flow and challenging blood vessels,
vascular malformations, and aneurysms.”
According to Pearson, the AZUR D35 Framing Coil offers
enhanced delivery control that allows for precise placement prior to final
deployment.
“The detachable technology allows the physician to optimize
the framing coil placement, creating support for subsequent coils,” said
Pearson. “AZUR D35 Hydrogel coils expand gradually upon exposure to blood,
which provides improved volumetric filling allowing highly effective, targeted embolization.
Physicians now have a complete coil embolization solution from Terumo.”
For more information about the AZUR product line, customers
can contact Terumo Interventional Systems by calling its Inside Sales
Specialist Team at 800-862-4143 or by visiting http://www.terumois.com.